Relevium Shares Perk Higher As Company Targets 30 New Products in Walmart by Year End

Shares of Relevium Technologies Inc. (TSX-Venture:RLV) (OTCQB:RLLVF) are perking higher as the Company announced this morning that it plans to increase its presence in and ramp up its current offering to over 30 SKUs before the end of the year.

Following the successful initial test launch of three SKUs, the Company is now ready to introduce up to 30 new SKUs of its Bioganix® Gold Series formulated products before the end of this year. The Company has also begun the regulatory and compliance process to launch its formulated products in the Canadian market and plans to test as soon as the products obtain natural health product approvals from Health Canada.

"We are working through the regulatory process to launch two (2) exclusive science based formulated products into the Canadian market and we are monitoring Walmart’s recently announced intention to explore the cannabis infused market as we see this as a potential platform for our LeefyLyfe® brand for North America" stated Aurelio Useche, Chief Executive Officer

As mentioned, shares of RLV are up $0.01 or 7.41% to $0.145 on the news. The stock has been on a roughly two-month uptrend and currently is flirting with key resistance around $0.15. A breakout of this level on strong conviction, could send shares significantly higher in the short-term.